In the SURMOUNT-1 trial, tirzepatide at 15 mg achieved a mean weight reduction of 20.9%, approximately 6 percentage points above semaglutide's best result in comparable populations
This type of study combines and analyzes results from multiple previous investigations in this case four observational studies that included nearly 37,000 pregnancies
Iwasaki, Y., Sendo, M., Dezaki, K
A survey from Gallup found the percentage of Americans taking GLP-1s jumped from 5.8 percent in early 2024 to 12.4 percent in mid-2025more than doubling in less than two years
Research Applications Tissue Repair & Regeneration BPC-157 and TB-500 accelerate fibroblast migration and angiogenesis, while GHK-Cu supports collagen remodeling, improving wound closure rates in animal studies [1]